In clinical practice, the deficiency of ACSS2 expression could serve as an independent prognostic factor predicting poorer prognosis in patients with gastric cancer, which was found to be especially correlated with Microsatellite Instability (MSI) (19). This evidence concerns the gene ACSS2 and gastric cancer.